Coastlands Capital LP
Overview
Coastlands Capital LP is a US-based hedge fund manager that primarily invests in equity and equity-related securities in U.S. and non-U.S. markets.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| CAMP4 | Dec 2025 | Follow-on Offering | Co-investor |
| LEXEO Therapeutics | May 2025 | Private Placement | Co-investor |
| Immunic | Feb 2026 | Post-IPO Financing | Co-investor |
| Quince Therapeutics | May 2026 | Private Placement | Co-investor |
| Palisade Bio | Oct 2025 | Follow-on Offering | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Coastlands Capital LP based?
Coastlands Capital LP is headquartered in San Francisco, California, United States.
When was Coastlands Capital LP founded?
Coastlands Capital LP was founded in 2025.
How many portfolio companies does Coastlands Capital LP have?
Coastlands Capital LP has 7 portfolio companies in Caplight's dataset.
What are some companies in Coastlands Capital LP's portfolio?
Portfolio companies visible on Caplight include CAMP4, LEXEO Therapeutics, Immunic, Quince Therapeutics, Palisade Bio.
What was Coastlands Capital LP's most recent investment shown here?
Coastlands Capital LP's most recent investment in this portfolio sample was in Quince Therapeutics in 2026.
What sectors does Coastlands Capital LP focus on?
Coastlands Capital LP focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Coastlands Capital LP focus on?
Coastlands Capital LP typically invests at the Early stage.
What is Coastlands Capital LP's AUM?
Coastlands Capital LP's assets under management are estimated between $408.7M and $606.0M.